Short Interest in Pharma Mar, S.A. (OTCMKTS:PHMMF) Rises By 43.4%

Pharma Mar, S.A. (OTCMKTS:PHMMFGet Free Report) was the recipient of a significant growth in short interest during the month of February. As of February 28th, there was short interest totalling 32,700 shares, a growth of 43.4% from the February 13th total of 22,800 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is currently 327.0 days. Approximately 0.2% of the company’s shares are short sold.

Pharma Mar Price Performance

Shares of PHMMF remained flat at $102.08 during mid-day trading on Monday. Pharma Mar has a 52-week low of $26.85 and a 52-week high of $105.60. The company has a quick ratio of 2.01, a current ratio of 2.55 and a debt-to-equity ratio of 0.14. The firm’s 50-day moving average is $92.24 and its 200 day moving average is $75.60.

Pharma Mar Company Profile

(Get Free Report)

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.

Featured Stories

Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.